Factors associated with suicidal ideation during the COVID-19 pandemic in a population in the Brazilian Legal Amazon

• Published in: Ciência & saude coletiva Vol. 27; no. 8; pp. 3157 - 3170
• Main Authors: Trettel, Ana Cláudia Pereira Terças, Muraro, Ana Paula, Oliveira, Elaine Cristina de, Nascimento, Vagner Ferreira do, Andrade, Amanda Cristina de Souza, Santos, Emerson Soares dos, Espinosa, Mariano Martinez, Pillon, Sandra Cristina
• Format: Journal Article
• Language: English
• Published: Rio de Janeiro Associação Brasileira de Saúde Coletiva 01.08.2022; ABRASCO - Associação Brasileira de Saúde Coletiva
• Subjects: Antibodies; Anxiety; Chemiluminescence; Coronaviruses; COVID-19; Drug use; Households; Mental depression; Mental disorders; Mental health; Municipalities; Pandemics; PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH; Severe acute respiratory syndrome coronavirus 2; Suicidal behavior; Suicidal ideation; Viral diseases; Brazil; Epidemiological surveys; SARS-CoV-2; Mental health; Saúde mental; Inquéritos epidemiológicos; Ideação suicida; Suicidal ideation
• ISSN: 1413-8123; 1678-4561; 1678-4561
• DOI: 10.1590/1413-81232022278.04972022

Abstract This article aims to analyze the factors associated with suicidal ideation in the COVID-19 pandemic. A cross-sectional home-based survey, with three-stage cluster sampling, was conducted with 4,203 adults from ten municipalities in the Mato Grosso, Brazil. The data collection was carried households to assessment of sociodemographic characteristics, substance use and behavior in the pandemic. The Level 1 Symptom Cross Scale was used to identify suicidal ideation and aspects of mental health (somatic symptoms, sleep disturbances, dissociation, depression, anger, mania, anxiety, thoughts, substance use and memory). Chemiluminescence was used to detect IgG anti-SARS-CoV-2 antibodies. The prevalence of suicidal ideation was 19.2%, and the associated with increased consumption of alcohol (RP=1.16), smoking (RP=1.30), COVID-19 symptoms (RP=1.03), having one’s life affected (RP=1.04), mental illness (RP=1.09) somatic symptoms (RP=1.15), sleep disturbance (RP=1.30), dissociation (RP=1.24), depression (RP=1.24), anger (RP=1.11), anxiety (RP=1.26), substance use (RP=1.19), drug prescription use (RP=1.18) and memory (RP=1.87). Highlights the high prevalence of suicidal ideation related to COVID-19 symptoms, changes in behavior post-pandemic and mental health factors. Resumo O objetivo deste artigo é analisar fatores associados a ideação suicida durante a pandemia da COVID-19. Inquérito de base populacional conduzido com 4.203 adultos de dez municípios mato-grossenses, Brasil. A coleta de dados foi realizada no domicílio, com avaliação de características sociodemográficas, uso de substâncias e comportamentos durante a pandemia. A Escala Transversal de Sintomas de Nível 1 do DSM-5 foi utilizada na identificação dos aspectos da saúde mental (sintomas somáticos, distúrbios do sono, dissociação, depressão, raiva, mania, ansiedade, pensamentos, uso de substâncias e memória) e utilizou-se quimioluminescência para detecção de anticorpos IgG anti-SARS-CoV-2. A prevalência de ideação suicida foi de 19,2%, e associou-se ao aumento do consumo de álcool (RP=1,16) e tabagismo (RP=1,30), sintomas de COVID-19 (RP=1,03), ter a vida muito afetada (RP=1,04), doença mental (RP=1,09), sintomas somáticos (RP=1,15), distúrbio do sono (RP=1,30), dissociação (RP=1,24), depressão (RP=1,24), raiva (RP=1,11), ansiedade (RP=1,26), uso de substâncias (RP=1,19), uso de medicamentos (RP=1,18) e memória (RP=1,87). Destacou-se a alta prevalência de ideação suicida e sua associação à sintomas de COVID-19, mudanças de comportamento pós-pandemia e fatores de saúde mental.